Home › Funds › Saturn V Capital Management LP › VIR

Saturn V Capital Management LP position in VIR

VIR BIOTECHNOLOGY INC · Health Care

Saturn V Capital Management LP reported holding 2,040,422 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q3 2026 13F filing — a position valued at US$22.8M, representing 3.34% of its reported portfolio and ranking #11 among its reported holdings. Saturn V Capital Management LP has disclosed VIR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.04M sh
Reported value held$22.81M
Portfolio Weight3.34%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's VIR position evolved

Saturn V Capital Management LP first disclosed a stake in VIR in Q2 2026 at 770,643 shares (US$7.9M). The position peaked in Q3 2026 at 2,040,422 shares, worth US$22.8M. Across 2 filings, Saturn V Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,040,422 shares valued at US$22.8M — an increase of 1,269,779 shares quarter over quarter.. Notable position changes include a 165% increase in Q3 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 770.64K $7.85M New
Q3 2026 2.04M $22.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VIR and 13F data

VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 42 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$95.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VIR

All VIR fund holders →

FAQ

How long has Saturn V Capital Management LP held VIR?

Saturn V Capital Management LP has disclosed VIR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Saturn V Capital Management LP's current position in VIR?

As of Q3 2026, Saturn V Capital Management LP holds 2.04M shares of VIR (VIR BIOTECHNOLOGY INC), valued at $22.81M, representing 3.34% of its reported portfolio and ranking #11.

Has Saturn V Capital Management LP been buying or selling VIR?

In the latest 13F filing (Q3 2026), Saturn V Capital Management LP increased its position in VIR. The position peaked in Q3 2026 at 2.04M shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.